glp 1 for hs Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 21 - Nov 26
![glp 1 for hs Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13098-025-01623-w/MediaObjects/13098_2025_1623_Figa_HTML.png)
![glp 1 for hs Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://www.mdpi.com/jcm/jcm-15-02909/article_deploy/html/images/jcm-15-02909-g002.png)
![glp 1 for hs Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://nextstepsinderm.com/wp-content/uploads/2025/12/JDD-Buzz_GLP-1.png)
![glp 1 for hs Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://www.researchgate.net/publication/396199809/figure/fig1/AS:11431281662477866@1759630049049/The-therapeutic-mechanism-of-GLP-1RAs-in-the-treatment-of-HS.png)






















